Women applications of a comparative bilateral female rats’ breast carcinoma findings

Main Article Content

Prof. Dr. Suhel M. Najjar, MB.Ch.,B.-D.G.S. -MSc.- PhD. Dr. Nali A. Maaruf, BVM&S.- MSc- PhD. Prof. Dr. Salah A. Ali, M.B.,Ch.B.- PhD.

Abstract

Background and objective: Breast carcinoma is the second most common type of cancer in women, and its incidences and consequences depend on internal congenital factors and various environmental chromosomal mutational factors. Multiple studies had evident heterogeneity in ipsilateral and contralateral breast cancers, of these the higher incidence of left breast cancer than right for indistinct reasons. This review article is concerned with the possibility of gathering the results of a recent research in comparison of bilateral rats' mammary cancer as a clue in evaluating the variations of the women’s right and left breast tumors. Bilateral breast's gross, microscopical consistency and the pathological, immunohistochemical expressions of both sides of breast tumors were studied, hoping to explain the disparity in bilateral breast cancer incidence and may exploit it for prophylactic purposes.


Material and methods:The study used two hundred virgin female Sprague Dawley rats aged 7 weeks, weighing 100–120g. The rats were divided into two groups: 50 rats used as a control group, which received a placebo, and 150 rats carcinogenic exposed group, which received a single oral dose of (7.12-Dimsthylbenz [a]anthracene (DMBA). Animals were weighed and monitored weekly until the end of the study. The lumps bilaterally appeared after induction and were excised for gross structural, histological, and immunohistochemical examinations. The study was also supplemented by normal women's bilateral mammography computerized technique (MATLAB) software analysis for gross anatomical study, as this was impossible in rats. Statistics data groups were analyzed using SPSS version 22.


Results: Among (150) rats exposed to DMBA, only (87) developed tumors as first noticed after (13-16) weeks. Tumors were distributed as 43.68% (38/87) on the right breasts, and 56.32% (49/87) on the left, including (5/87) bilateral, moreover to (11) right breast’s fibroadenoma. The weight and size of the tumors were greater on the right than left. Histopathological features of rat’s mammary cancer induced by DMBA were similar to those of human breast cancers regarding location, and histopathologic modifications, such as ductal carcinoma in situ, Invasive ductal carcinoma, lobular carcinoma in situ, and invasive lobular carcinoma. On the right side, Lobular carcinoma was observed tightly packed in clusters forming thin strands of cells arranged in a linear design (Indian file) with abundant eosinophilic infiltration, while on the left side carcinoma were disseminated irregularly in dense fibrous tissue and fat with less or damaged eosinophilic infiltrations.


The immunohistochemistry scores matched the tumor growth, susceptibility, and type. Estrogen receptors, progesterone receptors, and Kiel clone 67 (Ki67) expressions were higher with invasive ductal carcinoma. The invasive lobular carcinoma was negative for Human Epidermal Growth Factor Receptor 2 (HER2) and KI67. No triple-negative results were observed. The results of the women’s supplementary study by mammography analysis revealed that the majority of Iraqi females were heterogenous type III, and the left breast was denser than the right.


Conclusion: Among 150 rats only 58% developed various breast tumors after a single dose of carcinogens. The lower incidence of right breast carcinoma than the left is supposed to be due to the lower density, more fatty tissues, and lower immunity of the left breast. The left breast carcinomas were multifocal while the right breast carcinomas were localized in a single sector but characterized by a more aggressive cellular multiplication. Accordingly, if the revealed results are applied to women's breast carcinoma, it may lead to some important hints in understanding some secrets and mapping new management in breast carcinoma in the future.

Keywords: Breast carcinoma- eosinophils response- ductal carcinoma- lobular carcinoma- bilateral breast cancer.

Article Details

How to Cite
NAJJAR, Prof. Dr. Suhel M.; MAARUF, Dr. Nali A.; ALI, Prof. Dr. Salah A.. Women applications of a comparative bilateral female rats’ breast carcinoma findings. Medical Research Archives, [S.l.], v. 13, n. 1, jan. 2025. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/6261>. Date accessed: 10 feb. 2025. doi: https://doi.org/10.18103/mra.v13i1.6261.
Section
Research Articles

References

1. Arzanova E, Mayrovitz HN. The epidemiology of breast cancer. Exon Publications. 2022; 6:1-9.

2. Adesoye T, Irwin S, Sun SX, Lucci A, Teshome M. Contemporary surgical management of inflammatory breast cancer: a narrative review. Chin Clin Oncol.2021;10(6):57- 57

3. Kashyap D, Pal D, Sharma R, Garg VK, Goel N, Koundal D, Zaguia A, Koundal S, Belay A. [Retracted] Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures. Biomed Res Int. 2022;2022(1):9605439

4. Dumalaon-Canaria JA, Hutchinson AD, Prichard I, Wilson C. What causes breast cancer? A systematic review of causal attributions among breast cancer survivors and how these compare to expert-endorsed risk factors. Can Cau & Cont. 2014; 25:771-85

5. Kim S, Chaudhary PK, Upadhayaya S, Seo KW, Kim S. Histopathological and Immunohistochemical Characterization of Sebaceous Adenoma and Epithelioma in Dogs. Animals. 2024;14(10):1457.

6. Polyak K. Heterogeneity in breast cancer. J Clin Invest. 2011; 121(10):3786-8

7. Turashvili G, Brogi E. Tumor heterogeneity in breast cancer. Front Med. 2017; 8(4):227.

8. Maaruf NA, Najjar SM, Ali SA. Anatomical and Histopathological Comparative Studies Between Right and Left Mammary Tumors in a Rat Model Induced by DMBA. Pak Vet J. 2023; 1: 43(2).

9. Najjar, S.M.E. Pilot Study of Breast Cancer Patients with a Long Term Follow up in Erbil-Iraq. DJM. 2020 Dec 19 (2): 85-95

10. Foulkes WD. BRCA1 and BRCA2-update and implications on the genetics of breast cancer: a clinical perspective. Clin Genet. 2014; 1:85(1).

11. Shiovitz S, Korde LA. Genetics of breast cancer: a topic in evolution. Ann Oncol. 2015;26 (7):1291-9.

12. Ferreira T, Gama A, Seixas F, Faustino-Rocha AI, Lopes C, Gaspar VM, Mano JF, Medeiros R, Oliveira PA. Mammary glands of women, female dogs and female rats: similarities and differences to be considered in breast cancer research. Vet Sci. 2023;10(6):379.

13. Al Saad S, Al Shenawi H, Almarabheh A, Al Shenawi N, Mohamed AI, Yaghan R. Is laterality in breast Cancer still worth studying? Local experience in Bahrain. BMC cancer. 2022; 22(1):968

14. Avcı H, Karakaya J. A novel medical image enhancement algorithm for breast cancer detection on mammography images using machine learning. Diagnostics. 2023;13(3):348.

15. Anyfantis D, Koutras A, Apostolopoulos G, Christoyianni I. Breast Density Transformations Using CycleGANs for Revealing Undetected Findings in Mammograms. Signals. 2023; 4(2):421-38.

16. Simon SC, Utikal J, Umansky V. Opposing roles of eosinophils in cancer. Cancer Immunology, Immunotherapy. 2019; 68:823-33

17. Andreollo NA, Santos EF, Araújo MR, Lopes LR. Rat's age versus human's age: what is the relationship?. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 2012; 25:49-51.

18. Gearhart-Serna LM, Mills BA, Hsu H, Fayanju OM, Hoffman K, Devi GR. Cumulative environmental quality is associated with breast cancer incidence differentially by summary stage and urbanicity. Scientific Reports. 2023;13(1):20301.

19. Cynthia DeMarco. Is breast cancer more common on the left side? MD Anderson Cancer Center medical professional. 2023; (8): 9.

20. Moo TA, Sanford R, Dang C, Morrow M. Overview of breast cancer therapy. PET clinics. 2018; 13(3):339-354.

21. Abdou Y, Gupta M, Asaoka M, Attwood K, Mateusz O, Gandhi S, Takabe K. Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer. Scienti Repos. 2022; 12(1):13377.

22. Hammood ZD, Mohammed SH, Abdulla BA, Omar SS, Naqar S, Salih AM, Kakamad FH. Ductal carcinoma in situ arising from fibroadenoma; a rare case with review of literature. Ann med surg. 2022; 5(1):75.

23. Xu L, Luo S, Mao Q, Gao Y, Luo L, Qu W, Cao Y. Breast carcinoma arising in a fibroadenoma: A case series of 16 patients and review of the literature. Oncol Lett. 2023; 27(1):39.

25. Chimal-Ramírez GK, Espinoza-Sánchez NA, Fuentes-Pananá EM. Protumor activities of the immune response: insights in the mechanisms of immunological shift, oncotraining, and oncopromotion. J Oncol. 2013;(1):835956.

26. Cao C, Gu Y, Zhu C, Palmai-Pallag T, Lan F, Chen Z, Li W, Shen H, Ying S. Potential roles of eosinophils in cancer therapy: epidemiological studies, experimental models, and clinical pathology. Rece pate on anti-canc dru disco. 2014; 9(2):241-248.

27. Kylie L Gorringe, Stephen B Fox. Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis. Front Oncol. 2017; 23(7) :248.

28. Pate L, Desmedt C, Metzger O, et al. How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer Research. Cancers (Basel). 2021; 13:3094

29. Cho N. Molecular subtypes and imaging phenotypes of breast cancer. Ultras. 2016;35(4):281.